Mouse avatar models of esophageal squamous cell carcinoma proved the potential for EGFR-TKI afatinib and uncovered Src family kinases involved in acquired resistance

BACKGROUND: No approved targeted agents are available for esophageal squamous cell carcinoma (ESCC). Informative genomic analysis and mouse patient-derived xenografts (PDX) also called mouse avatar can greatly expedite drug discovery. METHODS: Six ESCC cell lines and 7 out of 25 PDX models derived f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhentao, Chen, Zuhua, Wang, Jingyuan, Zhang, Mengqi, Li, Zhongwu, Wang, Shubin, Dong, Bin, Zhang, Cheng, Gao, Jing, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114252/
https://www.ncbi.nlm.nih.gov/pubmed/30157900
http://dx.doi.org/10.1186/s13045-018-0651-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114252/
https://www.ncbi.nlm.nih.gov/pubmed/30157900
http://dx.doi.org/10.1186/s13045-018-0651-z

Ejemplares similares